Pillstats
Rx only · Tablet · Oral

Potassium Citrate

Potassium Citrate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA12BA02
RxCUI (US)54993
US makers4 labelers
Packages12
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.050$0.099$0.149$0.198Dec 2025Apr 2026Jul 2026
$0.170
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
3
Active US suppliers
80%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.8K5.5K8.3K11K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.6K
Rx · 2026 Q1
1.0M
Units dispensed
+49%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager5SUPPLYING
Strides Pharma Inc.unknown3SUPPLYING
BioComp Pharma, Inc.unknown2SUPPLYING
Upsher-Smith Laboratories, LLCunknown2EXITED 2027

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 18, 2018
    RECALLRecall (Class II): Potassium Citrate Extended-Release Tablets, USP, 15 mEq, 100-count bottles, Rx only, Manufactured for: Vensun Pharmaceu…

    Failed Tablet/Capsule Specifications: Tablet breakage — Recalling firm: VENSUN PHARMACEUTICALS INC — Within the United States and Puerto Rico.

  • Jul 18, 2018
    RECALLRecall (Class II): Potassium Citrate Extended-Release Tablets, USP, 10 mEq, 100-count bottles, Rx only, Manufactured for: Vensun Pharmaceu…

    Failed Tablet/Capsule Specifications: Tablet breakage — Recalling firm: VENSUN PHARMACEUTICALS INC — Within the United States and Puerto Rico.